PortfoliosLab logoPortfoliosLab logo
CPIX vs. PRE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CPIX vs. PRE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cumberland Pharmaceuticals Inc. (CPIX) and Prenetics Global Ltd (PRE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CPIX achieves a 67.84% return, which is significantly higher than PRE's 18.35% return.


CPIX

1D
-0.74%
1M
4.87%
6M
78.13%
YTD
67.84%
1Y
89.77%
3Y*
66.39%
5Y*
15.50%
10Y*
3.85%
ALL TIME*
-5.36%

PRE

1D
-3.12%
1M
10.10%
6M
-2.38%
YTD
18.35%
1Y
133.00%
3Y*
21.67%
5Y*
10Y*
ALL TIME*
-36.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$942.95K$842.80K$677.16K
$3.85M$4.87M$4.52M

CPIX vs. PRE - Yearly Performance Comparison


2026 (YTD)2025202420232022
CPIX
Cumberland Pharmaceuticals Inc.
67.84%67.93%32.28%-20.37%-1.32%
PRE
Prenetics Global Ltd
18.35%171.55%-1.86%-80.30%-76.19%

Correlation

The correlation between CPIX and PRE is 0.17, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.17

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (All Time)
Calculated using the full available price history since May 18, 2022

0.05

The correlation between CPIX and PRE shifts across timeframes, from 0.05 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CPIX:

$100.09M

PRE:

$316.89M

EPS

CPIX:

-$0.49

PRE:

-$4.54

PS Ratio

CPIX:

2.38

PRE:

2.56

PB Ratio

CPIX:

4.62

PRE:

2.61

Total Revenue (TTM)

CPIX:

$41.94M

PRE:

$113.75M

Gross Profit (TTM)

CPIX:

$34.76M

PRE:

$66.34M

EBITDA (TTM)

CPIX:

-$3.18M

PRE:

-$55.46M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CPIX vs. PRE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CPIX
CPIX Risk / Return Rank: 7777
Overall Rank
CPIX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
CPIX Sortino Ratio Rank: 7878
Sortino Ratio Rank
CPIX Omega Ratio Rank: 7777
Omega Ratio Rank
CPIX Calmar Ratio Rank: 7777
Calmar Ratio Rank
CPIX Martin Ratio Rank: 7474
Martin Ratio Rank

PRE
PRE Risk / Return Rank: 8686
Overall Rank
PRE Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
PRE Sortino Ratio Rank: 8383
Sortino Ratio Rank
PRE Omega Ratio Rank: 8080
Omega Ratio Rank
PRE Calmar Ratio Rank: 9191
Calmar Ratio Rank
PRE Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CPIX vs. PRE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cumberland Pharmaceuticals Inc. (CPIX) and Prenetics Global Ltd (PRE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CPIXPREDifference
Sharpe ratioReturn per unit of total volatility

-0.41

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

1.24

1.27

-0.03

Calmar ratioReturn relative to maximum drawdown

1.79

3.83

-2.05

Martin ratioReturn relative to average drawdown

3.71

8.67

-4.96

CPIX vs. PRE - Sharpe Ratio Comparison

The current CPIX Sharpe Ratio is 1.07, which is comparable to the PRE Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of CPIX and PRE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CPIX vs. PRE - Drawdown Comparison

The maximum CPIX drawdown since its inception was -93.78%, roughly equal to the maximum PRE drawdown of -97.70%. Use the drawdown chart below to compare losses from any high point for CPIX and PRE.


Loading charts...

Drawdown Indicators


CPIXPREDifference

Max Drawdown

Largest peak-to-trough decline

-93.78%

-97.70%

+3.92%

Max Drawdown (1Y)

Largest decline over 1 year

-52.62%

-34.36%

-18.26%

Max Drawdown (3Y)

Largest decline over 3 years

-71.94%

-72.73%

+0.79%

Max Drawdown (5Y)

Largest decline over 5 years

-84.73%

Max Drawdown (10Y)

Largest decline over 10 years

-86.68%

Current Drawdown

Current decline from peak

-60.81%

-85.21%

+24.40%

Average Drawdown

Average peak-to-trough decline

-70.69%

-86.78%

+16.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.34%

15.19%

+10.15%

Volatility

CPIX vs. PRE - Volatility Comparison

Cumberland Pharmaceuticals Inc. (CPIX) and Prenetics Global Ltd (PRE) have volatilities of 29.50% and 29.19%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CPIXPREDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.50%

29.19%

+0.31%

Volatility (6M)

Calculated over the trailing 6-month period

60.76%

61.04%

-0.28%

Volatility (1Y)

Calculated over the trailing 1-year period

88.18%

89.43%

-1.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

115.14%

88.68%

+26.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.01%

88.68%

-1.67%

Dividends

CPIX vs. PRE - Dividend Comparison

Neither CPIX nor PRE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CPIX vs. PRE - Financials Comparison

This section allows you to compare key financial metrics between Cumberland Pharmaceuticals Inc. and Prenetics Global Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

CPIX vs. PRE - Profitability Comparison

The chart below illustrates the profitability comparison between Cumberland Pharmaceuticals Inc. and Prenetics Global Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

CPIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a gross profit of 7.20M and revenue of 9.13M. Therefore, the gross margin over that period was 78.8%.

PRE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported a gross profit of 23.28M and revenue of 35.95M. Therefore, the gross margin over that period was 64.8%.

CPIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported an operating income of -3.13M and revenue of 9.13M, resulting in an operating margin of -34.3%.

PRE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported an operating income of -9.71M and revenue of 35.95M, resulting in an operating margin of -27.0%.

CPIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a net income of -3.29M and revenue of 9.13M, resulting in a net margin of -36.0%.

PRE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported a net income of -23.10M and revenue of 35.95M, resulting in a net margin of -64.3%.


Frequently Asked Questions


CPIX and PRE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CPIX has higher volatility (29.50%) compared to PRE (29.19%). In terms of maximum drawdown, CPIX dropped -93.78% vs PRE's -97.70%.

PRE currently has the higher Sharpe Ratio (1.47 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CPIX and PRE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer